Evidence map›Paper›PMID 40947452›Full record

ArticleJournal of neurology2025

Genetic background of neurological disorders with basal ganglia calcification.

Maha Yektay Farahmand, Joel Wallenius, Johan Wasselius, Olof Gråhamn, Andreas Puschmann, Andreea Ilinca

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maha Yektay FarahmandDivision of Neurology, Department for Clinical Sciences Lund, Lund University, Lund, Sweden.
Joel WalleniusDepartment of Neurology, Skåne University Hospital, Lund, Sweden.
Johan WasseliusDepartment of Radiology, Skåne University Hospital, Lund, Sweden.
Olof GråhamnDepartment of Neurology, Skåne University Hospital, Inga Marie Nilssons Gata 47, 205 02, Malmö, Sweden.
Andreas PuschmannDivision of Neurology, Department for Clinical Sciences Lund, Lund University, Lund, Sweden.
Andreea IlincaDivision of Neurology, Department for Clinical Sciences Lund, Lund University, Lund, Sweden. Andreea.Ilinca@med.lu.se.ORCID http://orcid.org/0000-0003-1979-5459

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBilateral basal ganglia calcifications (BGCs), if severe, are known hallmarks for idiopathic BGC disease (IBGC), but if milder, are often considered radiological findings of unknown significance. In previous studies, only a minority of patients with BGC had monogenic forms of IBGC.

methodsWe studied consecutive patients from a tertiary neurology clinic with bilateral BGCs of variable severity, and their families. We analyzed known IBGC genes, and an extended panel of genes linked to monogenic stroke and metabolic conditions. Clinical, radiological, and genetic data were collected, including vascular risk factors, cerebrovascular events, imaging findings (total calcification score, white matter hyperintensities, ischemic/hemorrhagic lesions), and relevant family history.

resultsTwenty-four families with BGCs and neurological symptoms were analyzed. Disease-causing variants were identified in 14 families (58.3%). Eight patients had IBGC (variants in SLC20A2, PDGFB, MYORG), 4 had mitochondrial disease (MT-TL1), and 2 had monogenic vascular conditions (GAL, MAP3K6). Three variants were novel. BGC severity was highest in IBGC cases, while vascular and mitochondrial cases had milder calcifications. White matter hyperintensities were seen in 94.7% of cases and correlated highly with the total calcification score. Clinical vascular events had occurred in 41.7% cases. No monogenic cause was found in 10 patients, although many of these showed clinical or radiological features suggestive of monogenic disease.

conclusionsBilateral BGCs can occur in many neurogenetic disorders apart from IBGCs, and a broader genetic search increases the diagnostic yield. Patients with BGCs frequently had clinical cerebrovascular events, which emphasizes the role of cerebrovascular pathology in BGCs.

Indexed as

Basal Ganglia DiseasesCalcinosisNervous System DiseasesAdultAgedFemaleGlycoside HydrolasesHumansMaleMiddle AgedMitochondrial DiseasesSodium-Phosphate Cotransporter Proteins, Type IIIYoung AdultGlycoside HydrolasesMYORG protein, humanSLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIBasal ganglia calcificationsMonogenic neurological disordersStrokeWhite matter hyperintensitiesWhole genome sequencing

Identifiers

PMID40947452
PMCPMC12433921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.